|
Re: Drug Combo Tames HER2+ Breast Cancer - SABCS2010
Tykerb isn't approved for preadjuvant therapy, Becky, so she wouldn't be able to get the combo if she dropped out of the trial. The most I think she would be able to switch to would be Herceptin alone, and since the difference there is slight, and she's tolerating the tykerb, I can't see the advantage there. I guess this is the chance you take when you sign up for a clinical trial. I just have to trust they will explain everything and do the best for her they can at Dana-Farber. :-(
|
Threaded Mode